Synthesis and Radiolabeling of Glu-Urea-Lys with 99m Tc-Tricarbonyl-Imidazole-Bathophenanthroline Disulfonate Chelation System and Biological Evaluation as Prostate-Specific Membrane Antigen Inhibitor
Cancer Biotherapy and Radiopharmaceuticals · 2023
DOI: 10.1089/cbr.2023.0024 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Biotherapy and Radiopharmaceuticals, 2023. Verfasst von Dara Hatamabadi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry and Radiopharmacy, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Antigens, Surface, Glutamate Carboxypeptidase II. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Chemistry and Radiopharmacy, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Department of Nuclear Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
- Peptide Chemistry Research Institute, K. N. Toosi University of Technolology, Tehran, Iran.
- Phytochemistry Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Radiation Application Research School, Nuclear Science and Technology Research Institute (NSTRI), Tehran, Iran.
- Medical Nanotechnology and Tissue Engineering Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
ORCID-Profile: Dara Hatamabadi, Mahnaz Ahmadi, Seyed Mohammad Ayyoubzadeh, Soraya Shahhosseini
Zitieren
APA
Hatamabadi, D., Joukar, S., Shakeri, P., Balalaie, S., Yazdani, A., Khoramjouy, M., Mazidi, S. M., Kobarfard, F., Mosayebnia, M., Bozorgchami, N., Ahmadi, M., Ayyoubzadeh, S. M., & Shahhosseini, S. (2023). Synthesis and Radiolabeling of Glu-Urea-Lys with 99m Tc-Tricarbonyl-Imidazole-Bathophenanthroline Disulfonate Chelation System and Biological Evaluation as Prostate-Specific Membrane Antigen Inhibitor. Cancer Biotherapy and Radiopharmaceuticals. https://doi.org/10.1089/cbr.2023.0024
Vancouver
Hatamabadi D, Joukar S, Shakeri P, Balalaie S, Yazdani A, Khoramjouy M, et al. Synthesis and Radiolabeling of Glu-Urea-Lys with 99m Tc-Tricarbonyl-Imidazole-Bathophenanthroline Disulfonate Chelation System and Biological Evaluation as Prostate-Specific Membrane Antigen Inhibitor. Cancer Biotherapy and Radiopharmaceuticals. 2023. doi:10.1089/cbr.2023.0024
BibTeX
@article{Hatamabadi2023,
author = {Hatamabadi, Dara and Joukar, Safura and Shakeri, Pegah and Balalaie, Saeed and Yazdani, Abdolreza and Khoramjouy, Mona and Mazidi, Seyed Mohammad and Kobarfard, Farzad and Mosayebnia, Mona and Bozorgchami, Negar and Ahmadi, Mahnaz and Ayyoubzadeh, Seyed Mohammad and Shahhosseini, Soraya},
title = {Synthesis and Radiolabeling of Glu-Urea-Lys with 99m Tc-Tricarbonyl-Imidazole-Bathophenanthroline Disulfonate Chelation System and Biological Evaluation as Prostate-Specific Membrane Antigen Inhibitor},
journal = {Cancer Biotherapy and Radiopharmaceuticals},
year = {2023},
doi = {10.1089/cbr.2023.0024}
}
EUVIMED